Information to marketing authorisation holders regarding variation applications after referral for medicinal products which contain the active substance finasteride or dutasteride
11.09.2025
more
11.09.2025
more
29.08.2025
more
18.07.2025
more
15.07.2025
more
16.06.2025
more
22.05.2025
more
19.05.2025
more
28.04.2025
more
25.04.2025
more
15.04.2025
more